These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 2936576

  • 1. Platelets and antiplatelet therapy in ischemic heart disease.
    Frishman WH, Miller KP.
    Curr Probl Cardiol; 1986 Feb; 11(2):69-136. PubMed ID: 2936576
    [No Abstract] [Full Text] [Related]

  • 2. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T, Samama M.
    Agents Actions Suppl; 1986 Feb; 20():203-14. PubMed ID: 3544741
    [No Abstract] [Full Text] [Related]

  • 3. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA.
    Cardiovasc Clin; 1987 Feb; 18(1):231-46. PubMed ID: 3300983
    [No Abstract] [Full Text] [Related]

  • 4. Antiplatelet agents: their role in the prevention of sudden death.
    Hirsh J.
    Ann N Y Acad Sci; 1982 Feb; 382():289-304. PubMed ID: 7044244
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Platelets and coronary heart disease: therapy update.
    Mehta JL.
    Geriatrics; 1982 May; 37(5):129-34, 139. PubMed ID: 7040169
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
    Van Aken WG.
    Adv Cardiol; 1982 May; 31():98-101. PubMed ID: 6758512
    [No Abstract] [Full Text] [Related]

  • 9. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B, Gitler ES.
    Am Heart J; 1983 Sep; 106(3):563-70. PubMed ID: 6410893
    [No Abstract] [Full Text] [Related]

  • 12. Antiplatelet therapy.
    Sloan RW.
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [Abstract] [Full Text] [Related]

  • 13. Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
    Eichner ER.
    Am J Med; 1984 Sep; 77(3):513-23. PubMed ID: 6383036
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of platelet-active drugs in coronary artery disease.
    Sherry S.
    Cardiovasc Clin; 1983 Sep; 14(1):173-89. PubMed ID: 6352025
    [No Abstract] [Full Text] [Related]

  • 19. Clinical aspects of antiplatelet therapy.
    Sherry S.
    Semin Hematol; 1985 Apr; 22(2):125-34. PubMed ID: 3890191
    [No Abstract] [Full Text] [Related]

  • 20. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J.
    Arch Intern Med; 1981 Feb 23; 141(3 Spec No):311-5. PubMed ID: 7008733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.